Jun 04, 2021 7:00am EDT CollPlant Announces Effectiveness of Uplisting to the Nasdaq Global Market®; Ordinary Shares Replace ADSs
May 27, 2021 7:00am EDT CollPlant Biotechnologies Reports First Quarter 2021 Financial Results with Record Revenues of $14.5 Million
May 25, 2021 9:00am EDT CollPlant Announces Uplisting to the Nasdaq Global Market® and Transition to Trading of Ordinary Shares Instead of ADSs
Mar 29, 2021 7:00am EDT CollPlant Appoints Additive Manufacturing Executive, Hugh Evans to Its Board of Directors
Mar 26, 2021 9:00am EDT CollPlant Biotechnologies Reports Year End Financial Results for Fiscal Year 2020
Feb 25, 2021 9:20am EST Termination of Licensing Agreement for Bioprinting of Scaffolds for Lung Transplants
Feb 18, 2021 7:00am EST CollPlant Announces Closing of $35.0 Million Registered Direct Offering of American Depositary Shares
Feb 11, 2021 11:22pm EST CollPlant Announces $35.0 Million Registered Direct Offering of American Depositary Shares